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PlcHR2A phospholipase C/sphingomyelinase from Pseudomonas aeruginosa has been assayed on vesicles containing
phosphatidylcholine, sphingomyelin, phosphatidylethanolamine and cholesterol at equimolar ratios. The
enzyme activity modiﬁes the bilayer chemical composition giving rise to diacylglycerol (DAG) and ceramide
(Cer). Assays of enzyme activity, enzyme-induced aggregation and fusion have been performed.
Ultrastructural evidence of vesicle fusion at various stages of the process is presented, based on cryo-EM
observations. The two enzyme lipidic end-products, DAG and Cer, have opposite effects on the bilayer
physical properties; the former abolishes lateral phase separation, while the latter generates a new gel phase
[Sot et al., FEBS Lett. 582, 3230–3236 (2008)]. Addition of either DAG, or Cer, or both to the liposome mixture
causes an increase in enzyme binding to the bilayers and a decrease in lag time of hydrolysis. These two
lipids also have different effects on the enzyme activity, DAG enhancing enzyme-induced vesicle aggregation
and fusion, Cer inhibiting the hydrolytic activity. These effects are explained in terms of the different physical
properties of the two lipids. DAG increases bilayers ﬂuidity and decreases lateral separation of lipids, thus
increasing enzyme activity and substrate accessibility to the enzyme. Cer has the opposite effect mainly
because of its tendency to sequester sphingomyelin, an enzyme substrate, into rigid domains, presumably
less accessible to the enzyme.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Membrane fusion is an essential event in a variety of cellular
processes, e.g., neurotransmitter release, certain viral infections
(inﬂuenza, HIV) or membrane biogenesis. The mechanism by which
the two involved bilayers transiently break down their structures to
becomea single continuousbilayer is not fully understoodyet. Themost
widely acceptedmodel of membrane fusion involves the formation of a
highly curved semitoroidal intermediate, “the stalk,” between the two
membranes [1]. It is known that the presence of diacylglycerol in the
membrane greatly facilitates membrane fusion [2–4].
Phospholipases are essential enzymes in maintaining membrane
homeostasis and in the generation of metabolic signals. They are also
powerful tools for bacteria to infect and eventually destroy eukaryoticcerol; LUV, large unilamellar
ol)-phosphatidylethanola; PC,
LC, phospholipase C; PlcHR2,
eruginosa; Rho-PE, rhodamine
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ll rights reserved.cells, helping in the degradation of the target cell membranes.
Phospholipases C (PLC) cleave the phosphodiester bond between
the glycerophospholipid DAG moiety and the phosphoryl groups.
Most sphingomyelinases hydrolyze the equivalent bond between
ceramide and phosphorylcholine in sphingomyelin (SM). From the
point of view of their enzyme activity, phospholipases, and lipases in
general, are rather unique among enzymes in that their substrates and
most end-products do not occur free in solution but are found instead
making part of cell membranes [5–8].
PlcHR2 is a novel phospholipase C/sphingomyelinase from Pseu-
domonas aeruginosa [9] equally active on PC and on SM when these
lipids are in the monomeric form, or in mixed micelles with
detergents. In a previous paper [10] we found that, when acting on
vesicles, the enzyme produces both DAG and Cer, which are in turn
responsible for vesicle aggregation, and fusion. Aggregation occurs
when DAG and/or Cer are formed in the membrane above a certain
level. Aggregation is necessary but not sufﬁcient for fusion to occur.
DAG, an end-product of the enzyme, induces membrane fusion [2,11–
13]. In the present work we have applied our previous knowledge to
study the effects of the end-products DAG and Cer on PlcHR2-induced
membrane fusion assayed in LUV in suspension.
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2.1. Materials
PlcHR2 was puriﬁed as previously described [9]. Egg phosphati-
dylcholine (PC), egg phosphatidylethanolamine (PE) and egg diacyl-
glycerol (DAG) were purchased from Lipid Products (South Nutﬁeld,
United Kingdom). Egg SM, egg Cer and cholesterol were from Avanti
Polar Lipids (Alabaster, AL). NBD-PE and Rho-PE were supplied by
Molecular Probes, Inc. (Eugene, OR).
2.2. LUV preparation
LUV of diameters 100–150 nm were prepared by the extrusion
method [14] using Nuclepore ﬁlters 0.1 or 0.2 μm pore diameter at
room temperature, in 25 mM HEPES, 100 mM NaCl, pH 7.2.
Quantitative analysis of the lipid composition of our LUV preparations,
as described by Ruiz-Argüello et al. [12], showed that it did not differ
signiﬁcantly from the initial lipid mixture. All experiments were
performed at 37 °C. Lipid concentration was 0.3 mM, and PlcHR2 was
used at 0.5 μg/ ml.
2.3. Cryo-electron microscopy
Samples were prepared under controlled conditons (37 °C, 99%
humidity) in a Vitrobot (Eindhoven, Nederland). 3 μl of a suspension
containing 10 mg phospholipid/ml were applied on a grid. After
careful spreading of the drop, excess liquid was immediately blotted
with ﬁlter paper. A 3-μl droplet creates a cylinder of about 0. 5-mm
thick on a grid and by blotting away excess liquid this cylinder is
reduced to a layer of about 100 nm. After blotting, the sample was
immediately plunged into liquid ethane held at its freezing point [15].
The specimen was transferred to a cryoholder of a microscope. After a
thermal equilibration period (20min), images are taken at 100 kV and
low-dose conditions in a Philips CM 12 microscope (Philips,
Eindhoven, the Netherlands).
2.4. PlcHR2 binding to vesicles
The intrinsic ﬂuorescence spectra of PlcHR2 either alone or in the
presence of vesicles were recorded in an Aminco Bowman Series 2
luminescence spectrometer equipped with a thermostated cell holder
and a magnetic stirrer. Small aliquots of a concentrated LUV
suspension were added to a ﬁxed concentration of enzyme solution
(3.5 μg/ ml) in a cuvette with continuous stirring, exciting the
samples at 295 nm and collecting emission between 300 and 420 nm.
The slit widths were 5 nm for both excitation and emission. The
intrinsic ﬂuorescence of PlcHR2 was titrated with increasing amounts
of lipid, in the 0–60 μM concentration range, added at 1. 5-min
intervals.
Spectra were corrected for the light scattered by the LUVs of
identical composition and concentration but in the absence of protein.
The signal was also corrected using the soluble Trp analogue, NATA,
which does not partition into membranes. The apparent mole fraction
coefﬁcients, Kx(app), were determined by ﬁtting the experimental
values to the hyperbolic function:
F = Fo = 1 +
Fmax = Fo − 1ð Þ L½ 
K + L½ 
where [L] is the lipid concentration and K is the lipid concentration at
which the bound enzyme fraction is 0.5. Therefore, Kx(app)=[W]/K,
where [W] is the molar concentration of water.The fraction of PlcHR2 bound to the membranes was estimated
according to the equation
fbound = Kx appð Þ L½ = W½  + Kx appð Þ L½ 
 
× 100
2.5. Enzyme activity
PlcHR2 activity was assayed by determining phosphorous contents
[16]. The liposome concentration was 0.3 mM in all experiments. For
optimal catalytic activity, the enzyme was assayed at 37 °C, in 25 mM
HEPES, 100 mM NaCl, pH 7.2. Enzyme concentration was 0.5 μg/ml.
Enzyme activity was assayed by determining water-soluble phospho-
rous. Aliquots (50 μl) were removed from the reaction mixture at
regular intervals and extracted with 250 μl of a chloroform/
methanol/hydrochloric acid mixture (66/33/1, v/v/v) and the
aqueous phase was assayed for phosphorous content.
2.6. Aggregation and ﬂuorescence measurements
Liposome aggregation was estimated as an increase in absorbance
at 500 nm, measured in a Uvikon 922 (Kontron instruments, Groβ-
Zimmern, Germany). Vesicle–vesicle fusion was assayed as mixing of
inner monolayer lipids by the resonance energy transfer method [17]
modiﬁed by Montes et al. [10], using NBD-PE and Rho-PE. Vesicles
containing 2% NBD-PE and 2% Rho-PE are brieﬂy treated with sodium
dithionite, a reagent that does not penetrate the membrane and that
bleaches the ﬂuorescence of the probes located in the outer
monolayers. The resulting vesicles, containing ﬂuorescent probes
only in the inner monolayer composition were mixed with probe-free
liposomes at 1:4 ratio. When vesicles fuse the inner monolayers of the
fusing vesicles become into contact, lipid mixing ensues, and the
subsequent probe dilution leads to decreased resonance energy
tranfers from NBD to rhodamine and increased NBD emission. NBD
emission was followed at 530 nm (excitation wavelength at 465 nm)
with a cut off ﬁlter at 515 nm. Zero percent mixing was established as
the equilibrium ﬂuorescence emission in the absence of enzyme. One
hundred percent mixing was set after addition of 1 mM Triton X-100.
These experiments were performed in an Aminco Bowman Series 2
luminescence spectrometer.
2.7. Statistics
Unless otherwise indicated, data are average values of three
independent measurements±1 standard deviation. Student's t-test
was used in order to assess the signiﬁcance of observed differences.
3. Results and discussion
3.1. Cryo-electron microscopy. Membrane fusion
As shown byMontes et al. on the basis of spectroscopic techniques
[18], the addition of PlcHR2 to LUVs composed by PC/PE/SM/Ch
(1:1:1:1) leads to extensive membrane fusion. Ultrastructural
evidence for this phenomenon is presented here using cryo-electron
micrographs taken at various times after enzyme addition (Fig. 1). At
0 min the size of the vesicles is 162±27 nm. After 2 min the vesicle
size does not change, probably because of the lag time of the enzyme
activity [7]. At longer times (5 min) some very large vesicles are seen,
together with others whose size has not changed. Finally, after 10 min
huge vesicles and vesicle aggregates (1156±285 nm) can be
observed. Inside these aggregates some of the honeycomb structures,
marked by arrows, arising from vesicles undergoing fusion events, are
found. These honeycomb patterns had been observed in the fusion of
Fig. 1. Cryo-TEM micrographs of LUV of PC/PE/SM/Ch (1:1:1:1) incubated with PlcHR2 at 37 °C for (A) 0 min, (B) 2 min, (C) 5 min and (D)10 min. Arrow in (D) indicates the
“honeycomb structures.”
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freeze-fracture and cryo-transmission electron microscopies.
3.2. Enzyme binding to vesicles
In order to estimate the enzyme afﬁnity for the various bilayer
compositions a ﬁxed concentration of the enzyme PlcHR2 (3.5 μg/ ml)
was titrated with increasing concentrations of lipid in the form of
LUVs up to 60 μM. The increase in ﬂuorescence was measured 1 min
after enzyme addition at 37 °C. Plots of ﬂuorescence intensity vs. lipid
concentration are shown in Fig. 2A. The enzyme binds the lipid with
much higher afﬁnity when DAG and/or Cer are present in the bilayer
(Table 1). The enzyme being catalytically active under these
conditions, it was possible that the data in Fig. 2A were inﬂuenced
by the presence of increasing amounts of DAG + Cer in the bilayer. In
order to overcome this difﬁculty, the initial rates of binding (or
maximum rates, when there was a lag time) were computed from
time-resolved studies of the increase in enzyme intrinsic ﬂuorescence
secondary to membrane binding. The results (Fig. 2B and Table 1)
conﬁrm that both DAG and Cer, either alone or in combination,
facilitate PlcHR2 binding to the lipid bilayers.
In a previous work where the lag time of the PC-PLC from B. cereus
[20] was studied, it was suggested that the enzyme worked at very
low rates during the initial period. Then, after a given concentration of
DAG had been reached in the bilayers, a kinetic transition occurred
and maximum rates of hydrolysis were observed. The same paper
described experiments showing that lag times became almost zero
when DAGwas present in themembrane before enzyme addition. The
data in Fig. 2 indicate that DAG or Cer increase dramatically PlcHR2
binding. With yet another enzyme, PI-PLC from B. cereus, Ahyayauch
et al. [21] observed that including DAG in bilayers increased enzyme
binding. Thus, it may be a general phenomenon that adding the lipidic
end-products of a lipase to a bilayer facilitates enzyme binding and
decreases the lag times of enzyme activity. The mechanism by which
addition of Cer or DAG enhances PlcHR2 binding cannot be ascertainedat present. In fact, the possibility of various coexisting mechanisms
cannot be ruled out. The data by Ahyayauch et al. [21] suggest that, in
general, increasing membrane ﬂuidity, e.g., by adding DAG [22],
facilitates enzyme binding; however, Cer gives rise to less ﬂuid
domains [22], yet it also enhances binding (Fig. 2). In the absence of
direct evidence, the hypothesis can be proposed that the enzyme has
an afﬁnity for the interfaces between the Cer-rich and -poor domains.
There are several examples of proteins that became preferentially
inserted at rigid–ﬂuid interfaces [20,23].
3.3. Enzyme activity. Vesicle aggregation and fusion
Montes et al. [18] have shown that PlcHR2 activity induces
aggregation and fusion of phospholipid vesicles (LUV) composed of
PC/SM/PE/Ch (1:1:1:1, mol ratio). In the present paper, we describe
the effects of including DAG and/or Cer in the initial composition. As
shown in Fig. 2A, the maximum rates of hydrolysis decrease when Cer
is present in the vesicle composition. Maximum rates rather than
initial rates are given because, as discussed by Montes et al. [18], a
latency period or lag time is observed with this enzyme, as with many
other lipases. When the extent of hydrolysis after 5 min, an
intermediate stage in the fusion process (Fig. 1C), is measured
(Fig. 3B). Cer but not DAG, is clearly seen to act as an enzyme inhibitor.
Our interpretation for the data in Fig. 3 is that, beyond their role as
end-product inhibitors, Cer and DAG have opposite physical proper-
ties that inﬂuence enzyme activity. Cer separates into rigid SM-Cer
domains [22,24], thus presumably a large fraction of the substrate SM
is not available to the enzyme. Recent evidence [25,26] with B. cereus
sphingomyelinase has shown that the enzyme acts in the ﬂuid phase
by producing oversaturation of ceramide which causes end-product
inhibition of the enzyme activity and eventually segregation of
ceramide-enriched domains.
On the contrary, DAG increases membrane ﬂuidity, and this
facilitates enzyme activity and compensates end-product inhibition.
Ahyayauch et al. [21] have shown for another PLC (PI-PLC from B.
Fig. 2. PlcHR2 binding to LUV of different lipid composition. (A) The enzyme has been
titrated with increasing concentrations of lipids. See main text for experimental details.
Control: basic lipid composition, consisting of an equimolar mixture of PC/PE/SM/Ch.
Average values ±S.D. (n=3).(B) The enzyme binding depending of the time.
Fig. 3. Activity of PlcHR2 for the four different lipid mixtures. (A) Maximum slopes. (B)
Extent of the activity. Average values ±S.D. (n=3). The asterisk denotes the results of
the Student's t-test. (⁎) 0.01bPb0.05; (⁎⁎) 0.001bPb0.01; (⁎⁎⁎) Pb0.001.
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ﬂuidity. The results with vesicles containing initially 5% Cer + 5% DAG
can be interpreted in the same way. DAG homogenizes or solubilizes
Cer-enriched domains, thus the observed decrease in enzyme rate
(Fig. 3A) is probably due to end-product inhibition. However, most of
the lipid is in the ﬂuid state, thus accessible to the enzyme, and this
explains the small difference in the amount of lipid cleaved after 5min
between the “control” and the “5% DAG+ 5% Cer” samples. Moreover,
it should be noted, from the comparison of Figs. 2 and 3, that there is
no correlation between enzyme binding and rates of hydrolytic
activity.Table 1
Effects of ceramide and/or diacylglycerol in bilayers originally composed of PC/SM/PE/
Ch (1:1:1:1, mol ratio).
Composition Enzyme bindinga
K0.5 (μM)
Enzyme binding
maximum ratesb (s−1)
PlcHR2 aggregation
lag timec (s)
Control 20±2.5 3±1 46±0.5
+10% Cer 3.0±0.325 8±0.5 12±0.5
+10% DAG 1.8±0.01 6±0.5 5±0.2
+5% Cer
+ 5% DAG
0.72±0.205 7±1 8±0.3
Data are average±S.D.
a Data derived from the experiments in Fig. 2A (n=3).
b Data derived from the experiments in Fig. 2B (n=3). Maximum rates are also the
initial rates when lag time is ≈0.
c Data derived from the experiments in Fig. 4 (n=3).PC and SM hydrolysis by PlcHR2 leads to vesicle aggregation. Lipid
hydrolysis and vesicle aggregation progress in parallel with this [10]
and other lipases [27,28]. Aggregation is assayed as an increase in light
scattering by the vesicle suspension [18]; thus, light scattering
measurements provide a convenient method to measure lag times.
Time-courses of enzyme-induced LUV aggregation are shown in Fig. 4.Fig. 4. Time-course PlcHR2-induced LUV aggregation, for the three different lipid
compositions. Aggregation is assayed as an increase in suspension turbidity (A500). A
latency period is clearly observed for the control vesicles.
Fig. 5. PlcHR2-induced LUV aggregation. (A)Maximum slopes. (B) Extent of aggregation
(A500) after 5 min, under apparent steady-state conditions. Average values±S.D.
(n=3–4). The asterisk denotes the results of the Student's t-test. (⁎) 0.01bPb0.05;
(⁎⁎) 0.001bPb0.01; (⁎⁎⁎) Pb0.001.
Fig. 6. PlcHR2-induced intervesicular mixing of inner monolayer lipids. (A) Maximum
slopes for the various lipid compositions. (B) Dose–response effect of DAG. Average
values±S.D. (n=3). The asterisk denotes the results of the Student's t-test. (⁎)
0.01bPb0.05; (⁎⁎) 0.001bPb0.01; (⁎⁎⁎) Pb0.001.
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after which maximum aggregation rates are observed. Aggregation
lag times for the four populations of LUV under study are given in
Table 1. There is a very good parallelism between enzyme afﬁnity for
the vesicles (data from experiments in Fig. 2) and lag times (data from
experiments in Fig. 3). We conclude that PlcHR2 behaves as shown
previously for Bacillus PC-PLC [27]: the latency period is decreased
when a small proportion of the end-product is present from the
beginning of the enzyme assay. Moreover, the combined observations
of Figs. 2 and 4 indicate that the transition from the slow to the fast
regime of enzyme activity is accompanied (caused) by the increased
binding of enzyme. Note also the lack of correlation between lag times
(Table 1) and maximum enzyme activity (Fig. 3). A ceramide-
increased binding of B. cereus sphingomyelinase and subsequent
enhancement of the precatalytic steps (lag time shortening) was
thoroughly described and kinetically analysed by Fanani et al. [29]
working on lipid monolayers at the air–water interface.
The rates and extents of LUV aggregation induced by PlcHR2 are
shown in Fig. 5. The maximum rates (slopes) appear to be
independent of lipid composition, the increase observed for the
mixture containing DAG being statistically non-signiﬁcant. The
extents of aggregation after 5 min, when an apparent equilibrium
has been reached, follow a somewhat similar pattern as the
corresponding data for lipid hydrolysis (Fig. 3B), ceramide inhibition
being the main result. A ceramide-dependent decrease in enzyme
activity was also found by Fanani et al. [29] for B. cereus sphingo-
myelinase. The data in Fig. 5 conﬁrm a trend that has been observed
previously for other PLCs, namely that aggregation appears to be a
direct effect of lipid cleavage.
As shown for other PLCs [12,28,30–32] enzyme-induced LUV
aggregation may lead, under certain circumstances, to vesicle fusion.
This is also the case for PlcHR2, as shown by Montes et al. [18] and in
Fig. 1. Among the various available fusion assays, the inner monolayerlipid mixing assay is particularly speciﬁc for intervesicular fusion, as
distinct from hemifusion [18,28]. Results for vesicles containing DAG
and/or Cer are summarized in Fig. 6A. Only maximum slopes are
given, because in this kind of assay the total extent of fusion cannot be
reliably ascertained. As shown in Fig. 6A, 10% DAG increases
signiﬁcantly the fusion rate, while Cer, or DAG + Cer mixtures are
not effective. The data in Fig. 6B show that the enhancing effect of DAG
is dose-dependent. This conﬁrms our previous observations
[2,11,12,32–35] that DAG, but not Cer, is a potent fusogen.
Previous studies have pointed out the mutual modulation of
phospholipase C and sphingomyelinases when these enzymes are
added separately to a lipid bilayer [32,36]. In our case, we have both
activity associated to a single protein, but the interplay of bilayer
physical properties and enzyme activities is probably very similar. In
our former study with PlcHR2 [18] we described that the catalytic
activity of the enzyme that cleaves PC and SM at about the same rates
induced vesicle fusion in the absence of vesicular leakage. In the
present contribution we have explored in further detail the effects of
the enzyme end-products DAG and Cer. From the various assays of
enzyme activity and enzyme-induced vesicle aggregation and fusion,
we conclude that both DAG and Cer decrease the lag times of lipid
hydrolysis, that Cer inhibits the PlcHR2 hydrolytic activity, and that
DAG increases fusion rates. The observed decrease in lag times
conﬁrms our previous observation that, in PLCs, the latency period is
used to accumulate a certain amount of lipid end-product, and that
the lag time can be substantially decreased if the corresponding end-
product is already present in the bilayer at the time of enzyme
addition [27]. Cer inhibition of the enzyme hydrolytic activity appears
to be due mainly to lateral segregation of rigid SM-Cer domains [22],
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fusion by DAG is probably related to the ability of DAG to give rise to
the inverted non-lamellar phases whose structure is reproduced in
the fusion intermediate “stalk” [1,11,13].
Whether the mechanisms demonstrated in our model system
would also be applicable to cell membranes remains an open
question. The observed effects, including gel-phase separations, that
require a relatively high concentration of enzyme end-products could
indeed exist, although certainly limited in space and time to a
particular region (nanodomain?) of the membrane and for a short
time. However, the current technologies are still unable to detect
these small, transient domains in an unambiguous way.
Finally, the observations reported herein that ceramide formation
inhibits PlcHR2 hydrolytic activity seems to be counter intuitive in the
context of the recently reported biological activities [37] associated
with this protein. That is, the cytotoxicity of PlcHR2 appears to be
mediated primarily by its sphingomyelinase activity rather than its
PC-PLC activity. This is the consequence of the fact that PlcHR2 induces
a calcium signalling-mediated apoptosis in the endothelial cells,
which strongly suggest that its cytotoxicity is mediated by the
generation of ceramide, rather through the generation of DAG. On the
other hand, this interpretation may be overly simplistic since PlcHR2,
besides being PC-PLC and a SMase, also has sphingomyelin synthase
activity [38]. That is, it can remove the phosphorylcholine head group
of PC and then transfer it to ceramide, resulting in a net synthesis of
sphingomyelin. Accordingly, further studies of the biochemistry and
biophysics as described in this report may help in dissecting the
mechanisms by which very low concentrations of PlcHR2 (i.e.,
picomolar) are selectively cytotoxic to endothelial cells and the
mechanisms by which this protein causes the hemolysis of sheep
erythrocytes, which have virtually no PC in their outer leaﬂet of their
membranes, which in terms of their lipids are essentially composed
only of sphingomyelin [39].
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